Med Dev Biz Guy

From POS
to BOD.

And most places in between.

I'm Pete. Nearly twenty years in medical devices, from working point-of-sale in the OR at 3 a.m. to delivering valuation models to the Board. I've trained spine surgeons on novel procedural tech, helped close M&A deals worth half a billion dollars, and now I'm building commercial infrastructure at a venture-backed advanced surgical visualization startup.

CFA Charterholder Johns Hopkins MBA Mattawan, MI

I've lived both sides of the transaction.

Most med tech executives know one side of the business. Sales people don't model deals. Finance people don't guide surgeons through surgery. I've done both — for two decades.

I started at NuVasive as a clinical wonk, running surgeon education and clinical marketing programs because I genuinely wanted to understand how value gets delivered in the OR. Then I traded the office for a bag and carried NuVasive's spine portfolio across the Pacific Northwest for 1,000+ surgical cases, earning President's Club honors. Next, I pivoted to corporate development at CONMED, where I helped close $500M+ in acquisitions, led a $40M sell-side divestiture, and built the company's first M&A due diligence playbook from scratch.

Today I'm Director of Market Development at Activ Surgical, a venture-backed advanced surgical visualization company. I'm building Board-level market and valuation models, BD pipeline management infrastructure, competitive intelligence, and distributor support materials.

Along my journey, I picked up an MBA in Finance from Johns Hopkins and earned my CFA Charter. Because credibility matters when you're making the case to surgeons, boards, and investors.

$500M+
in M&A transactions closed at CONMED
1,000+
surgical cases supported in the OR
200+
surgeons trained on novel procedural tech
20y
in medical devices & surgical technology

Twenty years, five companies, one through-line: translation.

AS
2025 — Present
Director, Market Development
Activ Surgical · Boston, MA · Venture-Backed Advanced Surgical Visualization
CN
2022 — 2025
Director, Strategy & Corporate Development
CONMED Corporation · NYSE: CNMD
CN
2020 — 2022
Territory Manager, Advanced Surgical
CONMED Corporation · Southern Oregon · #1 in PNW Region
NV
2014 — 2019
Sales Representative, Spine
NuVasive (NYSE: NUVA, acquired by Globus Medical 2023) · Pacific Northwest
NV
2008 — 2014
Manager, Clinical Marketing & International Sales
NuVasive · San Diego, CA · Surgeon Education program management
AP
2005 — 2008
Account Manager / SME / Inside Sales
APC by Schneider Electric · Including expat assignment in the Philippines

Two acquisitions. Eight months. Half a billion dollars.

i.
In2Bones
Foot & ankle.
CONMED's strategic expansion into extremities. Led valuation modeling, financial diligence, and integration planning. Structured deal terms including earn-outs and synergy assumptions presented to executive leadership and the Board.
Sector Orthopedic Extremities
Role Lead Analyst
ii.
Biorez
Bioresorbable soft tissue regeneration.
Strategic platform addition to CONMED's sports medicine portfolio. Drove valuation analysis, scenario modeling, and synergy quantification across commercial, manufacturing, and R&D workstreams.
Sector Sports Medicine / Regenerative
Role Lead Analyst
Also led a ~$40M sell-side divestiture of CONMED's gastroenterology portfolio from inception through sell-side due diligence. Process continued after departure; exit announced publicly within weeks.

Where clinical depth meets capital rigor.

01

M&A & Corporate Development

Buy-side and sell-side. DCF, comparable company analysis, LBO, earn-out structuring, synergy quantification, scenario sensitivity. End-to-end deal execution from sourcing through integration.

02

Market Modeling & Strategy

Bottom-up TAM/SAM/SOM models. Procedure volume forecasts. Adoption curves. Competitive landscape analysis. Board-level market opportunity assessments and investment recommendations.

03

Early-Stage Commercial Build

Building commercial infrastructure from zero at venture-backed companies. OEM licensing frameworks, BD pipeline systems, value proposition development, KOL recruitment, field enablement materials.

04

Surgical Domain Expertise

Spine (MIS, lateral, complex deformity). General surgery. Surgical robotics and advanced visualization. Imaging. Minimally invasive procedures. Health economics and reimbursement.

05

KOL Engagement & Clinical Validation

Recruiting and managing Clinical Advisory Boards. Voice-of-customer research with surgeons and hospital administrators. Translating clinical feedback into product requirements and market strategy.

06

Field Sales Leadership

President's Club performer. 1,000+ surgical cases supported. 200+ surgeons trained. Direct experience with the full sales cycle, surgeon engagement, capital sales, and account expansion.

Let's talk.

Whether you're a venture-backed company building from zero, a PE firm looking at a med tech asset, or a fellow operator thinking about what's next — happy to connect.